S&P 500

5.652,41

0,38%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Allos Therapeutics, Inc. (MM) (ALTH)
Allos Therapeutics, Inc. (MM) (ALTH) Notícias

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:ALTH

<< Anterior 4 5 6 7 8 9 10 11 12 13 14

Data	Hora	Fonte	Título	Código	Companhia
11/03/2004	17:17	PR Newswire (US)	American Stock Exchange to Trade Options on Three Securities	NASDAQ:ALTH
05/03/2004	20:59	PR Newswire (US)	Allos Therapeutics Files Shelf Registration Statement	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
12/02/2004	10:45	PR Newswire (US)	Reminder - Allos Therapeutics Management Conference Call	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
12/02/2004	10:00	PR Newswire (US)	Allos Begins Phase 3 Study of RSR13 in Women With Brain Metastases From Breast Cancer	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
12/02/2004	09:00	PR Newswire (US)	Allos Therapeutics Reports Fourth Quarter and Year-End 2003 Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
04/12/2003	09:00	PR Newswire (US)	Allos Completes New Drug Application for Novel Treatment for Patients With Breast Cancer and Brain Metastases	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/12/2003	20:30	PR Newswire (US)	Arizona Cancer Center Investigator Presents Positive Survival and Quality of Life Data From RSR13 Phase 3 Study	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
24/11/2003	10:00	PR Newswire (US)	Allos Therapeutics Announces RSR13 Phase 3 Results in Patients With Breast Cancer and Brain Metastases Will Be Highlighted at th	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/11/2003	20:24	PR Newswire (US)	Allos Therapeutics Completes $12 Million Private Placement	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
18/11/2003	15:30	PR Newswire (US)	Allos Therapeutics Announces Presentation of Phase 1 Results of PDX in Patients With Advanced Non-Small Cell Lung Cancer	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
17/11/2003	09:00	PR Newswire (US)	Allos Therapeutics Announces Presentation of RSR13 Phase 3 Results in Brain Metastases at the Eighth Annual Meeting of the Socie	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
15/11/2003	17:00	PR Newswire (US)	RSR13 Investigator Presented With National Tumor Foundation Research Award At Society for Neuro-Oncology Annual Meeting	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/11/2003	10:45	PR Newswire (US)	Reminder - Webcast Alert: Allos Therapeutics, Inc. Announces Third Quarter 2003 Financial Results Conference Call on the Web	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/11/2003	09:00	PR Newswire (US)	Allos Therapeutics Reports Third Quarter 2003 Financial Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
31/10/2003	10:45	PR Newswire (US)	Webcast Alert: Allos Therapeutics, Inc. Announces Third Quarter 2003 Financial Results Conference Call on the Web	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)